1 Guillerm G, "p16INK4a and p15INK4b gene methylations in plasma cells from monoclonal gammopathy of undetermined significance" 98 : 244-246, 2001
2 Ribas C, "p16 gene methylation lacks correlation with angiogenesis and prognosis in multiple myeloma" 222 : 247-254, 2005
3 Gonzalez-Paz N, "Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications" 109 : 1228-1232, 2007
4 Ries LAG MD KM, "SEER Cancer Statistics Review" National Cancer Institute
5 Ohashi H, "Relationship between methylation of the p15 gene and ectopic expression of the EVI-1 gene in myelodysplastic syndromes (MDS)" 15 : 990-991, 2001
6 Bladé J, "Prognostic factors for multiple myeloma in the era of novel agents" 19 (19): 7117-7120, 2008
7 Dominguez G, "Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors" 530 : 9-17, 2003
8 Shiraz OB, "Possible down regulation of the p16 gene promoter in individuals with hepatocellular carcinoma" 11 : 719-723, 2011
9 McKenna RW, "Plasma cell neoplasm, In WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed" IARC 200-213, 2008
10 Harousseau JL, "Multiple myeloma: ESMO clinical recommendations for diagnosis, treatment and follow-up" 19 (19): 255-257, 2008
1 Guillerm G, "p16INK4a and p15INK4b gene methylations in plasma cells from monoclonal gammopathy of undetermined significance" 98 : 244-246, 2001
2 Ribas C, "p16 gene methylation lacks correlation with angiogenesis and prognosis in multiple myeloma" 222 : 247-254, 2005
3 Gonzalez-Paz N, "Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications" 109 : 1228-1232, 2007
4 Ries LAG MD KM, "SEER Cancer Statistics Review" National Cancer Institute
5 Ohashi H, "Relationship between methylation of the p15 gene and ectopic expression of the EVI-1 gene in myelodysplastic syndromes (MDS)" 15 : 990-991, 2001
6 Bladé J, "Prognostic factors for multiple myeloma in the era of novel agents" 19 (19): 7117-7120, 2008
7 Dominguez G, "Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors" 530 : 9-17, 2003
8 Shiraz OB, "Possible down regulation of the p16 gene promoter in individuals with hepatocellular carcinoma" 11 : 719-723, 2011
9 McKenna RW, "Plasma cell neoplasm, In WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed" IARC 200-213, 2008
10 Harousseau JL, "Multiple myeloma: ESMO clinical recommendations for diagnosis, treatment and follow-up" 19 (19): 255-257, 2008
11 Herman JG, "Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands" 93 : 9821-9826, 1996
12 Tanaka R, "Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma" 103 : 608-615, 2005
13 Hari PN, "Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant" 23 : 1528-1534, 2009
14 Durie BG, "International uniform response criteria for multiple myeloma" 20 : 1467-1473, 2006
15 Greipp PR, "International staging system for multiple myeloma" 23 : 3412-3420, 2005
16 Smadja NV, "Hypodiploidy is a major prognostic factor in multiple myeloma" 98 : 2229-2238, 2001
17 Guzman LM, "High frequency of p16 promoter methylation in non-small cell lung carcinomas from Chile" 40 : 365-372, 2007
18 Avet-Loiseau H, "Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome" 109 : 3489-3495, 2007
19 Brenner H, "Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010" 94 : 270-275, 2009
20 Yuregir OO, "Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients" 32 : 142-149, 2010
21 Zheng S, "Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors" 21 : 2057-2064, 2000
22 Park G, "Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: a methylation-specific polymerase chain reaction study using two different primer sets" SPRINGER 90/2011 (90/2011): 73-79, 2011
23 Göhring G, "Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome" 116 : 3766-3769, 2010
24 Jemal A, "Cancer statistics, 2008" 58 : 71-96, 2008
25 Goto T, "Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer" 29 : 275-277, 2009
26 Martin P, "Aberrant gene promoter methylation in plasma cell dyscrasias" 84 : 256-261, 2008
27 Durie BG, "A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival" 36 : 842-854, 1975